Enzyme complex from Trichoderma reesei and P. funiculosum enzymes

US10119129B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10119129-B2
Application numberUS-201013318850-A
CountryUS
Kind codeB2
Filing dateMay 7, 2010
Priority dateMay 7, 2009
Publication dateNov 6, 2018
Grant dateNov 6, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention relates to an improved enzyme complex having a plurality of enzyme activities of an expression product obtained by fermentation of the genus Trichoderma in combination with one or more enzymes of a different fungus strain.

First claim

Opening claim text (preview).

The invention claimed is: 1. An enzyme complex having beta-1,4-endoglucan hydrolase activity comprising: a. a fermentation product of Trichoderma reesei wherein at least 61 % of the beta-1,4-endoglucan hydrolase activity of the enzyme complex, as measured by the “Assay 1” method, is from the fermentation product of Trichoderma reesei; and b. one or more enzymes derived from Penicillium funiculosum selected from a xylanase (EC 3.2.1.8), a cellulase (EC 3.2.1.4), and a beta-glucanase (EC 3.2.1.6), wherein 30% to 39% of the beta-1,4-endoglucan hydrolase activity of the enzyme complex, as measured by the “Assay 1” method, is from a fermentation product of Penicillium funiculosum; wherein the enzyme complex is substantially cell free. 2. The enzyme complex according to claim 1 , wherein said one or more enzymes derived from Penicillium funiculosum is an expression product obtained by fermentation of said Penicillium funiculosum. 3. The enzyme complex according to claim 2 , which expression product obtained by fermentation of said Penicillium funiculosum comprises a xylanase. 4. The enzyme complex according to claim 1 , further comprising one or more enzyme activities selected from the list consisting of endo-1,4-β-xylanase, endo-1,3(4)-β-glucanase, cellulase, laminarinase, endo-1,5-α-L arabinanase, beta-D-glucoside glucohydrolase, β-Xylosidase, cellobiohydrolase, glucan 1,4-beta-glucosidase, xyloglucan-specific exo-beta-1,4-glucanase and α-N Arabinofuranosidase. 5. An enzyme complex having beta-1,4-endoglucan hydrolase activity comprising: a. a first expression product obtained by fermentation of Trichoderma reesei , wherein the first expression product accounts for at least 61% of the beta-1,4-endoglucan hydrolase activity of the enzyme complex; and b. a second expression product obtained by fermentation of Penicillium funiculosum, wherein the second expression product accounts for at least 39% of the beta-1,4-endoglucan hydrolase activity of the enzyme complex; wherein the percentages of beta-1,4-endoglucan hydrolase activity are measured by the “Assay 1” method; wherein the enzyme complex is substantially cell free. 6. The enzyme complex according to claim 1 , wherein said strain is Trichoderma reesei deposited under the Budapest treaty in the American Type Culture Collection (ATCC) having a strain designation GC Cellulose A83 GICC 0004, M03000004 deposited by Danisco A/S on the date of 5 May 2009, or a derivative or progeny thereof. 7. The enzyme complex according to claim 2 , wherein said expression product obtained by fermentation of a Penicillium fungus is from single culture of the species Penicillium funiculosum. 8. The enzyme complex according to claim 7 , wherein said strain is Penicillium funiculosum deposited under the Budapest treaty in the International Mycological Institute under the number IMI 378536, or a derivative or progeny thereof. 9. The enzyme complex according to claim 1 , wherein said expression product obtained by fermentation is from a wild type species. 10. The enzyme complex according to claim 1 , having an enzyme activity of at least about 3000 U/g, such as at least about 4000 U/g, such as at least about 5000 U/g, such as at least about 6000 U/g, such as at least about 7000 U/g as measured by “Assay 1” as described herein derived from fermentation of Trichoderma reesei. 11. The enzyme complex according to claim 1 , having a total enzyme activity of at least about 4000 U/g as measured by “Assay 1”as described herein. 12. The enzyme complex according to claim 1 , wherein about 2362 U/g beta-1,4-endoglucan hydrolase activity is from a fermentation product of Penicillium funiculosum and wherein about 5315 u/g U/g beta-1,4-endoglucan hydrolase activity is from a fermentation product of Trichoderma reesei wherein said units/g (U/g) is determined by “Assay1”. 13. The enzyme complex according to claim 1 , wherein said enzyme complex contains at least 5 different side activities. 14. The enzyme complex of claim 1 or claim 5 further comprising at least one preservative.

Assignees

Inventors

Classifications

  • Immunosuppressants, e.g. drugs for graft rejection · CPC title

  • Antineoplastic agents · CPC title

  • for joint disorders, e.g. arthritis, arthrosis · CPC title

  • C12N9/2437Primary

    Cellulases (3.2.1.4; 3.2.1.74; 3.2.1.91; 3.2.1.150) · CPC title

  • Endo-1,4-beta-xylanase (3.2.1.8) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10119129B2 cover?
The invention relates to an improved enzyme complex having a plurality of enzyme activities of an expression product obtained by fermentation of the genus Trichoderma in combination with one or more enzymes of a different fungus strain.
Who is the assignee on this patent?
Fish Neville Marshall, Miller Lone Broend, Dupont Nutrition Biosci Aps
What technology area does this patent fall under?
Primary CPC classification C12N9/2437. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Nov 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).